Format

Send to

Choose Destination
See comment in PubMed Commons below
Curr Opin Cell Biol. 2009 Apr;21(2):140-6. doi: 10.1016/j.ceb.2009.01.028. Epub 2009 Mar 9.

Tyrosine phosphorylation: thirty years and counting.

Author information

1
The Salk Institute, La Jolla, CA 92037, USA. hunter@salk.edu

Abstract

In the 30 years since its discovery, tyrosine phosphorylation has emerged as a fundamentally important mechanism of signal transduction and regulation in all eukaryotic cells, governing many processes, including cell proliferation, cell cycle progression, metabolic homeostasis, transcriptional activation, neural transmission, differentiation and development, and aging. Perturbations in tyrosine phosphorylation underlie many human diseases, and in particular cancer, and this has prompted the development of inhibitors of tyrosine kinases implicated in disease, a number of which have been approved for clinical use. The following is a brief personal reflection on some of the salient findings over the past 30 years that led to the development of tyrosine kinase inhibitors for disease therapy.

PMID:
19269802
PMCID:
PMC2670436
DOI:
10.1016/j.ceb.2009.01.028
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science Icon for PubMed Central
    Loading ...
    Support Center